Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 16
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Norway Approves Public Funding for Generic Ketamine in Treatment-Resistant Depression
July 2025 Psychedelic Patent Update
Dr Case Newsom – Creating Safe Spaces: The Zendo Project’s Approach...
The Psychedelics & Pain Symposium 2025
Growing Attention To Psychedelics For Pain, Physical & Neurological Conditions
Kat Murti – Students for Sensible Drug Policy, Meta Censorship, and...
Reunion Neuroscience Posts Strong Phase 2 Results for RE104 in Postpartum...
Toad, Truth, and the Trouble with 5-MeO: Why Bufo alvarius Needs...
One Year After FDA’s MDMA Rejection: Insiders and Observers Reflect
Harry Pack NFT – Last Call
Load more